ARTICLE | Clinical News
Reolysin: Phase III ongoing
June 25, 2012 7:00 AM UTC
Oncolytics said an independent DMC recommended continuation of the double-blind, placebo-controlled, international Phase III REO 018 trial evaluating IV Reolysin in combination with carboplatin and pa...